Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors

Molecular Therapy

Volumn 22, Issue 1, 2014, Pages 140-148

  Balyasnikova, Irina V ^a   Prasol, Melanie S ^a   Ferguson, Sherise D ^a   Han, Yu ^a   Ahmed, Atique U ^a   Gutova, Margarita ^c   Tobias, Alex L ^a   Mustafi, Devkumar ^b   Rincón, Esther ^a   Zhang, Lingjiao ^a   Aboody, Karen S ^a   Lesniak, Maciej S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL INDIUM IN 111; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER SURVIVAL; CELL MIGRATION; CELL TRANSPORT; CEREBELLUM; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL BRAIN TUMOR; GAMMA IRRADIATION; GLIOBLASTOMA; HISTOLOGY; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NOSE CAVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; STEM CELL GENE THERAPY; TUMOR XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRACKING; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; GAMMA RAYS; GENE EXPRESSION; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; ORGANOMETALLIC COMPOUNDS; OXYQUINOLINE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891807513     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.199     Document Type: Article

References (47)

1. Legler, JM, Ries, LA, Smith, MA, Warren, JL, Heineman, EF, Kaplan, RS et al. (1999). Cancer surveillance series [corrected]: Brain and other central nervous system cancers: Recent trends in incidence and mortality. J Natl Cancer Inst 91: 1382-1390
2. Stupp, R, Mason, WP, Van Den Bent, MJ, Weller, M, Fisher, B, Taphoorn, MJ et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996
3. Serwer, LP and James, CD (2012). Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerations. Adv Drug Deliv Rev 64: 590-597
4. Lee, DH, Ahn, Y, Kim, SU, Wang, KC, Cho, BK, Phi, JH et al. (2009). Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res 15: 4925-4934
5. Nakamizo, A, Marini, F, Amano, T, Khan, A, Studeny, M, Gumin, J et al. (2005). Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318
6. Fischer, UM, Harting, MT, Jimenez, F, Monzon-Posadas, WO, Xue, H, Savitz, SI et al. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 18: 683-692
7. Lappalainen, RS, Narkilahti, S, Huhtala, T, Liimatainen, T, Suuronen, T, Närvänen, A et al. (2008). The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci Lett 440: 246-250
8. Li, L, Jiang, Q, Ding, G, Zhang, L, Zhang, ZG, Li, Q et al. (2010). Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab 30: 653-662
9. Pendharkar, AV, Chua, JY, Andres, RH, Wang, N, Gaeta, X, Wang, H et al. (2010). Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 41: 2064-2070
10. Walczak, P, Zhang, J, Gilad, AA, Kedziorek, DA, Ruiz-Cabello, J, Young, RG et al. (2008). Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39: 1569-1574
11. Burgess, A, Ayala-Grosso, CA, Ganguly, M, Jordão, JF, Aubert, I and Hynynen, K (2011). Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PLoS ONE 6: E27877
12. Danielyan, L, Schäfer, R, von Ameln-Mayerhofer, A, Buadze, M, Geisler, J, Klopfer, T et al. (2009). Intranasal delivery of cells to the brain. Eur J Cell Biol 88: 315-324
13. Danielyan, L, Schäfer, R, von Ameln-Mayerhofer, A, Bernhard, F, Verleysdonk, S, Buadze, M et al. (2011). Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res 14: 3-16
14. van Velthoven, CT, Kavelaars, A, van Bel, F and Heijnen, CJ (2010). Nasal administration of stem cells: A promising novel route to treat neonatal ischemic brain damage. Pediatr Res 68: 419-422
15. Reitz, M, Demestre, M, Sedlacik, J, Meissner, H, Fiehler, J, Kim, SU et al. (2012). Intranasal delivery of neural stem/progenitor cells: A noninvasive passage to target intracerebral glioma. Stem Cells Transl Med 1: 866-873
16. Hao, C, Beguinot, F, Condorelli, G, Trencia, A, Van Meir, EG, Yong, VW et al. (2001). Induction and intracellular regulation of tumor necrosis factor-related apoptosisinducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res 61: 1162-1170
17. Kuijlen, JM, Bremer, E, Mooij, JJ, den Dunnen, WF and Helfrich, W (2010). Review: On TRAIL for malignant glioma therapy? Neuropathol Appl Neurobiol 36: 168-182
18. Ehtesham, M, Kabos, P, Gutierrez, MA, Chung, NH, Griffith, TS, Black, KL et al. (2002). Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 62: 7170-7174
19. Kim, SM, Lim, JY, Park, SI, Jeong, CH, Oh, JH, Jeong, M et al. (2008). Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 68: 9614-9623
20. Klopp, AH, Spaeth, EL, Dembinski, JL, Woodward, WA, Munshi, A, Meyn, RE et al. (2007). Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 67: 11687-11695
21. Kim, SM, Oh, JH, Park, SA, Ryu, CH, Lim, JY, Kim, DS et al. (2010). Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factorrelated apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells 28: 2217-2228
22. Heyn, C, Ronald, JA, Mackenzie, LT, MacDonald, IC, Chambers, AF, Rutt, BK et al. (2006). In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med 55: 23-29
23. Adamina, M, Rosenthal, R, Weber, WP, Frey, DM, Viehl, CT, Bolli, M et al. (2010). Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma. Mol Ther 18: 651-659
24. Shapiro, EM, Gonzalez-Perez, O, Manuel García-Verdugo, J, Alvarez-Buylla, A and Koretsky, AP (2006). Magnetic resonance imaging of the migration of neuronal precursors generated in the adult rodent brain. Neuroimage 32: 1150-1157
25. Valable, S, Barbier, EL, Bernaudin, M, Roussel, S, Segebarth, C, Petit, E et al. (2007). In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage 37 (suppl. 1): S47-S58
26. Wu, YL, Ye, Q, Foley, LM, Hitchens, TK, Sato, K, Williams, JB et al. (2006). In situ labeling of immune cells with iron oxide particles: An approach to detect organ rejection by cellular MRI. Proc Natl Acad Sci USA 103: 1852-1857
27. Zhao, D, Najbauer, J, Garcia, E, Metz, MZ, Gutova, M, Glackin, CA et al. (2008). Neural stem cell tropism to glioma: Critical role of tumor hypoxia. Mol Cancer Res 6: 1819-1829
28. Park, SA, Ryu, CH, Kim, SM, Lim, JY, Park, SI, Jeong, CH et al. (2011). CXCR4- transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Int J Oncol 38: 97-103
29. Xu, F, Shi, J, Yu, B, Ni, W, Wu, X and Gu, Z (2010). Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncol Rep 23: 1561-1567
30. Bexell, D, Gunnarsson, S, Tormin, A, Darabi, A, Gisselsson, D, Roybon, L et al. (2009). Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17: 183-190
31. Wu, X, Hu, J, Zhou, L, Mao, Y, Yang, B, Gao, L et al. (2008). In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation. J Neurosurg 108: 320-329
32. Bossolasco, P, Cova, L, Levandis, G, Diana, V, Cerri, S, Lambertenghi Deliliers, G et al. (2012). Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease. Int J Nanomedicine 7: 435-447
33. Crawford, J (2013). Childhood brain tumors. Pediatr Rev 34: 63-78
34. Thu, MS, Najbauer, J, Kendall, SE, Harutyunyan, I, Sangalang, N, Gutova, M et al. (2009). Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS ONE 4: E7218
35. Marini, P, Schmid, A, Jendrossek, V, Faltin, H, Daniel, PT, Budach, W et al. (2005). Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis. BMC Cancer 5: 5
36. Shankar, S, Singh, TR and Srivastava, RK (2004). Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms. Prostate 61: 35-49
37. Zielske, SP, Livant, DL and Lawrence, TS (2009). Radiation increases invasion of gene-modified mesenchymal stem cells into tumors. Int J Radiat Oncol Biol Phys 75: 843-853
38. Zhang, D, Fan, GC, Zhou, X, Zhao, T, Pasha, Z, Xu, M et al. (2008). Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. J Mol Cell Cardiol 44: 281-292
39. Haider, HKh, Jiang, S, Idris, NM and Ashraf, M (2008). IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103: 1300-1308
40. Wei, N, Yu, SP, Gu, X, Taylor, TM, Song, D, Liu, XF et al. (2013). Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant 22: 977-991
41. Li, Y, Yu, X, Lin, S, Li, X, Zhang, S and Song, YH (2007). Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 356: 780-784
42. Lledo, PM, Gheusi, G and Vincent, JD (2005). Information processing in the mammalian olfactory system. Physiol Rev 85: 281-317
43. Balyasnikova, IV, Franco-Gou, R, Mathis, JM and Lesniak, MS (2010). Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface. J Tissue Eng Regen Med 4: 247-258
44. Balyasnikova, IV, Ferguson, SD, Han, Y, Liu, F and Lesniak, MS (2011). Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts. Cancer Lett 310: 148-159
45. Gildehaus, FJ, Haasters, F, Drosse, I, Wagner, E, Zach, C, Mutschler, W et al. (2011). Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo. Mol Imaging Biol 13: 1204-1214
46. Huang, HS, Nagane, M, Klingbeil, CK, Lin, H, Nishikawa, R, Ji, XD et al. (1997). The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 272: 2927-2935
47. Nishikawa, R, Ji, XD, Harmon, RC, Lazar, CS, Gill, GN, Cavenee, WK et al. (1994). A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 91: 7727-7731